Genomic Cancer Driver Study Reveals New Clues to Aggressive Prostate Cancer

An international research team co-led by the Ontario Institute for Cancer Research and the University of Copenhagen has identified new genomic clues explaining why some prostate cancers progress slowly while others rapidly become life-threatening metastatic disease. The study analyzes genetic drivers within prostate cancer genomes to understand the mechanisms behind aggressive tumor behavior. These findings could help clinicians better predict which patients face higher risk of rapid progression and enable more personalized treatment strategies. Understanding these genomic differences is crucial for improving outcomes in prostate cancer patients who face variable disease trajectories.